Your response to GLP-1 may not match the timing below
These medications, although related, have distinct uses and dosages tailored to individual needs
Efficacy and safety of once-weekly semaglutide versus once-daily insulin glargine as add-on to metformin (with or without sulfonylureas) in insulin-naive patients with type 2 diabetes (SUSTAIN 4): a randomised, open-label, parallel-group, multicentre, multinational, phase 3a trial
APPEAL PROCESS What to Do If Medicare Denies Wegovy Medicare Appeals Have High Success Rates Over 80% of Medicare Advantage prior authorization appeals succeed yet only about 11% of patients ever appeal, according to KFF analysis of CMS data
The decision between semaglutide and Contrave should align with your individual medical profile, weight loss goals, lifestyle preferences, and tolerance for different side effect profiles